Tsourapas Panagiotis
SEC CIK 1576945 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CL | Colgate-Palmolive | Grp Pres, LatAm, AsiaPac, AF, Eus | 11.4K | — | $27.22M | 47 | 2021-12-08 | 2026-09-16 |
Most active insiders at CL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wallace Noel R. | COB, Pres, CEO, Dir | — | $33.98M |
| 2 | SUTULA STANLEY J III | CFO | — | $9.22M |
| 3 | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | — | $5.70M |
| 4 | Massey Sally | CHRO | — | $2.36M |
| 5 | Daniels Jennifer | CLO, Sec | — | $2.08M |
| 6 | Hazlin John | Chief Growth Off | — | $1.98M |
| 7 | Malcolm Gregory | EVP, Ctrl | — | $1.41M |
| 8 | CAHILL JOHN T | Dir | — | $389.4K |
| 9 | Fishbone Betsy | CLO, Sec | — | — |
| 10 | GRANT SHANE | COO, Americas | — | — |
Transactions 47
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 16:10 | 2026-09-16 | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | A - Grant | $0.00 | +4,597 | 11.4K | +67% | $0 |
| M | 2026-09-15 16:11 | 2026-09-11+ | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | F - Tax | $86.80 | -2,224 | 6,850 | -25% | -$193.0K |
| I | 2026-08-26 16:47 | 2026-08-24 | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | S - Sale | $92.05 | -10.0K | 64.9K | -13% | -$920.5K |
| 2026-02-25 | 2026-02-23 | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | A - Grant | $0.00 | +25.7K | 34.7K | +287% | $0 | |
| 2026-02-25 | 2026-02-23 | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | F - Tax | $97.10 | -13.1K | 21.6K | -38% | -$1.27M | |
| DM | 2026-02-13 | 2026-02-11+ | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | S - Sale+OE | $95.57 | -50.0K | 10.4K | -83% | -$4.78M |
| DM | 2026-02-13 | 2026-02-11+ | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | M - OptEx | $76.41 | +50.0K | 45.4K | New | +$3.82M |
| 2025-12-05 | 2025-12-03 | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | F - Tax | $78.20 | -221 | 10.4K | -2% | -$17.3K | |
| M | 2025-09-16 | 2025-09-12+ | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | F - Tax | $83.28 | -1,421 | 11.5K | -11% | -$118.3K |
| D | 2025-09-12 | 2025-09-11 | CL | Colgate-Palmolive | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | A - Grant | $0.00 | +4,759 | 12.0K | +66% | $0 |
| 2025-02-18 | 2025-02-13 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | F - Tax | $87.75 | -7,827 | 17.9K | -30% | -$686.8K | |
| 2025-02-18 | 2025-02-13 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | A - Grant | $0.00 | +18.6K | 25.7K | +262% | $0 | |
| 2024-12-05 | 2024-12-03 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | F - Tax | $94.61 | -168 | 7,111 | -2% | -$15.9K | |
| I | 2024-11-05 | 2024-11-04 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale | $93.30 | -20.0K | 49.2K | -29% | -$1.87M |
| D | 2024-09-16 | 2024-09-12 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | A - Grant | $0.00 | +3,630 | 8,801 | +70% | $0 |
| D | 2024-09-16 | 2024-09-13 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | F - Tax | $105.73 | -762 | 8,039 | -9% | -$80.6K |
| D | 2024-08-12 | 2024-08-08 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $72.29 | +14.8K | 19.9K | +287% | +$1.07M |
| D | 2024-08-12 | 2024-08-08 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $102.94 | -14.8K | 5,146 | -74% | -$1.52M |
| D | 2024-08-02 | 2024-07-31 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $72.29 | +40.0K | 45.1K | +777% | +$2.89M |
| D | 2024-08-02 | 2024-07-31 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $99.47 | -40.0K | 5,146 | -89% | -$3.98M |
| D | 2024-05-10 | 2024-05-09 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $94.15 | -12.0K | 5,118 | -70% | -$1.13M |
| D | 2024-05-10 | 2024-05-09 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $72.29 | +12.0K | 17.1K | +234% | +$867.5K |
| M | 2024-02-20 | 2024-02-15+ | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | F - Tax | $83.53 | -8,164 | 18.5K | -31% | -$682.0K |
| 2024-02-20 | 2024-02-15 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | A - Grant | $0.00 | +11.0K | 23.2K | +90% | $0 | |
| I | 2024-02-07 | 2024-02-05 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | I - Discretionary | $84.09 | -836 | 0 | -100% | -$70.3K |
| D | 2024-02-02 | 2024-01-31 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $84.41 | -30.4K | 12.1K | -72% | -$2.57M |
| D | 2024-02-02 | 2024-01-31 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $68.16 | +30.4K | 42.6K | +251% | +$2.07M |
| 2023-12-08 | 2023-12-06 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | F - Tax | $77.47 | -245 | 12.1K | -2% | -$19.0K | |
| D | 2023-11-30 | 2023-11-28 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $77.83 | -15.0K | 12.4K | -55% | -$1.17M |
| D | 2023-11-30 | 2023-11-28 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $68.16 | +15.0K | 27.4K | +121% | +$1.02M |
| D | 2023-11-14 | 2023-11-10 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $68.16 | +20.0K | 32.3K | +163% | +$1.36M |
| D | 2023-11-14 | 2023-11-10 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $75.36 | -20.0K | 12.3K | -62% | -$1.51M |
| D | 2023-09-15 | 2023-09-13 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | A - Grant | $0.00 | +5,301 | 12.3K | +76% | $0 |
| D | 2023-05-12 | 2023-05-10 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $73.00 | +13.7K | 20.6K | +198% | +$1000.0K |
| DI | 2023-05-12 | 2023-05-10 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $81.01 | -2,404 | 822 | -75% | -$194.7K |
| D | 2023-05-12 | 2023-05-10 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $81.08 | -13.7K | 6,906 | -66% | -$1.11M |
| DM | 2023-05-05 | 2023-05-03+ | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $80.88 | -55.0K | 6,906 | -89% | -$4.45M |
| DM | 2023-05-05 | 2023-05-03+ | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $73.00 | +55.0K | 26.9K | New | +$4.01M |
| 2023-02-21 | 2023-02-16 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | F - Tax | $72.77 | -3,138 | 13.1K | -19% | -$228.4K | |
| 2023-02-21 | 2023-02-16 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | A - Grant | $0.00 | +9,361 | 16.3K | +136% | $0 | |
| D | 2022-08-17 | 2022-08-16 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | F - Tax | $82.18 | -34.0K | 8,788 | -79% | -$2.79M |
| D | 2022-08-17 | 2022-08-16 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $72.99 | +36.0K | 42.8K | +528% | +$2.63M |
| 2022-02-22 | 2022-02-17 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | A - Grant | $0.00 | +14.3K | 21.1K | +213% | $0 | |
| 2022-02-22 | 2022-02-17 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | F - Tax | $79.15 | -5,804 | 15.3K | -28% | -$459.4K | |
| D | 2022-02-11 | 2022-02-09 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | S - Sale+OE | $81.00 | -25.0K | 6,701 | -79% | -$2.02M |
| D | 2022-02-11 | 2022-02-09 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, Eur, Developing Mkts | M - OptEx | $72.99 | +25.0K | 31.7K | +373% | +$1.82M |
| 2021-12-10 | 2021-12-08 | CL | Colgate-Palmolive | Tsourapas Panagiotis | Grp Pres, LatAm, AsiaPac, AF, Eus | F - Tax | $77.76 | -337 | 6,701 | -5% | -$26.2K |
Purchase Sale Sale after option exercise All abbreviations